MUCINOUS ENDOMETRIAL CARCINOMA

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting MUCINOUS ENDOMETRIAL CARCINOMA:

# Drug Count
0 CARBOPLATIN 1
1 DOSTARLIMAB 1
2 PACLITAXEL 1
3 PACLITAXEL (AIBUMIN-BOUND) 1
4 RALOXIFENE HYDROCHLORIDE 1
See all common drugs associated with MUCINOUS ENDOMETRIAL CARCINOMA

MUCINOUS ENDOMETRIAL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOSTARLIMAB 1 0.0004
1 PACLITAXEL 1 0.0000
2 CARBOPLATIN 1 0.0000
See all drugs enriched for association with MUCINOUS ENDOMETRIAL CARCINOMA

These drug classes are most commonly taken by patients reporting MUCINOUS ENDOMETRIAL CARCINOMA:

# Drug class Count
0 Microtubule Inhibitor [EPC] 1
1 Platinum-based Drug [EPC] 1
See all common drug classes associated with MUCINOUS ENDOMETRIAL CARCINOMA

MUCINOUS ENDOMETRIAL CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Microtubule Inhibitor [EPC] 1 0.0000
1 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with MUCINOUS ENDOMETRIAL CARCINOMA